References
- Pizzuti D, Buda A, D'Odorico A, D'Incà R, Chiarelli S, Curioni A, Martines D. Lack of intestinal mucosal toxicity of Triticum monococcum in celiac disease patients. Scand J Gastroenterol 2006; 41: 1305–11
- Frazer AC, Fletcher RF, Ross CA, Shaw B, Sammons HG, Schneider R. Gluten-induced enteropathy. The effect of partially digested gluten. Lancet 1959; 2: 252–5
- Alvarez JB, Moral A, Martin LM. Polymorphism and genetic diversity for the seed storage proteins in Spanish cultivated einkorn wheat (Triticum monococcum L. ssp. monococcum). Genet Resources Crop Evol 2006; 53: 1061–7
- Ciclitira PJ, Evans DJ, Fagg NL, Lennox ES, Dowling RH. Clinical testing of gliadin fractions in coeliac patients. Clin Sci (Lond) 1984; 66: 357–64
- Ensari A, Marsh MN, Moriarty KJ, Moore CM, Fido RJ, Tatham AS. Studies in vivo of omega-gliadins in gluten sensitivity (coeliac sprue disease). Clin Sci (Lond) 1998; 95: 419–24
- Sjøstrøm H, Lundin KEA, Molberg Ø, Korner R, McAdam SN, Anthonsen D, et al. Identification of a gliadin T-cell epitope in coeliac disease: general importance of gliadin deamidation for intestinal T-cell recognition. Scand J Immunol 1998; 48: 111–5
- Dewar DH, Amato M, Ellis HJ, Pollock EL, Gonzalez-Cinca N, Wieser H, et al. The toxicity of high molecular weight glutenin subunits of wheat to patients with coeliac disease. Eur J Gastroenterol Hepatol 2006; 18: 483–91
- Shan L, Molberg Ø, Parrot I, Hausch F, Filiz F, Gray GM, et al. Structural basis for gluten intolerance in celiac sprue. Science 2002; 297: 2275–9
- van Herpen TWJM, Goryunova SV, van der Schoot J, Mitreva M, Salentijn E, Vorst O, et al. Alpha-gliadin genes from the A, B, and D genomes of wheat contain different sets of celiac disease epitopes. BMC Genomics 2006; 7: 1
- Marsh MN, Morgan S, Ensari A, Wardle T, Lobley R, Mills C, et al. In vivo activity of peptides 31–43, 44–55. 56–68 of α-gliadin in gluten sensitive enteropathy. Gastroenterology 1995; 108: A871
- Sturgess R, Day P, Ellis HJ, Lundin KE, Gjertsen HA, Kontakou M, et al. Wheat peptide challenge in coeliac disease. Lancet. 1994; 343: 758–61
- Maiuri L, Ciacci C, Ricciardelli I, Vacca L, Raia V, Auricchio S, et al. Association between innate response to gliadin and activation of pathogenic T cells in coeliac disease. Lancet. 2003; 362: 30–7
- Anderson O, Greene FC. The α-gliadin gene family. II. DNA and sequence variation, subfamily structure, and origins of pseudogenes. Theor Appl Genetics 1997; 95: 59–65
- Arentz-Hansen EH, McAdam SN, Molberg O, Kristiansen C, Sollid LM. Production of a panel of recombinant gliadins for the characterisation of T cell reactivity in coeliac disease. Gut 2000; 46: 46–51
- Jabri B, Sollid LM. Mechanisms of disease: immunopathogenesis of celiac disease. Nat Clin Pract Gastroenterol Hepatol 2006; 3: 516–25
- Kasarda DD, Bernardin JE, Qualset CO. Relationship of gliadin protein components to chromosomes in hexaploid wheats (Triticum aestivum L). Proc Natl Acad Sci USA 1976; 73: 3646–50
- Falchuk ZM, Nelson DL, Katz AJ, Bernardin JE, Kasarda DD, Hague NE, et al. Influence of histocompatibility type on gluten sensitivity in vitro J Clin Invest 1980; 66: 227–33
- de Ritis G, Auricchio S, Jones HW, Lew EJ-L, Bernardin JE, Kasarda DD. In vitro (organ culture) studies of the toxicity of specific A-gliadin peptides in celiac disease. Gastroenterology 1988; 94: 41–9